Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › AZ › Flagstaff › NPI 1558544817
Lab

Technical Resource Management LLC

Technical Resource Management LLC was paid $14.69M by Medicaid between Jan 2018 and Dec 2024, across 14 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 82% of everything it billed.

33Billing provider infoTECHNICAL RESOURCE MANAGEMENT LLC
FLAGSTAFF, AZ 86004
33aNPI1558544817assigned 12/10/2007
28Total paid$14.69M
24GClaims506,145
24DCodes billed14
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Arizona

Rank by total paid#4 of 67
Median peer was paid$89K
This provider vs. median165×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201846,947$946K
201961,182$1.29M
202081,637$2.21M
202184,660$2.46M
202285,883$2.92M
202394,952$3.24M
2024incomplete50,884$1.62M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 82% 443,980 218,774 $12.09M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 16% 39,873 17,414 $2.33M
80349 <1% 7,253 4,051 $110K
80324 <1% 2,718 1,621 $41K
80321 <1% 2,411 1,806 $36K
80348 <1% 2,341 913 $21K
80365 <1% 1,387 907 $21K
80361 <1% 1,367 754 $21K
81025 <1% 4,411 3,922 $14K
80346 <1% 207 149 $2K
80354 <1% 60 50 $574.89
82945 <1% 100 81 $383.16
2 more codes
80373 <1% 23 $304.72
80353 <1% 14 $186.66

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRANGEL, ELIZABETH (DIRECTOR OF BILLING AND COLLECTIONS)